Choreo LLC lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 191.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,507 shares of the medical instruments supplier's stock after buying an additional 15,446 shares during the period. Choreo LLC's holdings in DENTSPLY SIRONA were worth $440,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in XRAY. Pacer Advisors Inc. increased its position in shares of DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after buying an additional 4,473,972 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the period. Invenomic Capital Management LP acquired a new position in DENTSPLY SIRONA in the 3rd quarter worth $23,724,000. National Bank of Canada FI boosted its stake in DENTSPLY SIRONA by 85.8% in the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock worth $44,059,000 after purchasing an additional 751,800 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in DENTSPLY SIRONA by 50.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock worth $55,900,000 after purchasing an additional 692,100 shares during the period. Institutional investors own 95.70% of the company's stock.
Analyst Ratings Changes
XRAY has been the subject of a number of research analyst reports. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday, November 8th. Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday, November 7th. Wells Fargo & Company initiated coverage on shares of DENTSPLY SIRONA in a research note on Friday. They issued an "equal weight" rating and a $20.00 target price for the company. Morgan Stanley reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research note on Tuesday, December 17th. Finally, Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Ten investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus target price of $25.85.
Read Our Latest Stock Report on XRAY
DENTSPLY SIRONA Trading Down 2.4 %
Shares of DENTSPLY SIRONA stock traded down $0.45 during trading on Friday, hitting $18.32. The company's stock had a trading volume of 2,580,852 shares, compared to its average volume of 2,164,900. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $34.91. The stock has a market cap of $3.64 billion, a price-to-earnings ratio of -8.85, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96. The stock has a 50-day moving average price of $19.02 and a two-hundred day moving average price of $21.89.
DENTSPLY SIRONA Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.49%. DENTSPLY SIRONA's payout ratio is -30.92%.
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Recommended Stories

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.